Novavax files for emergency use listing of COVID-19 vaccine with WHO

Earlier on Monday, Novavax and its partner Serum Institute of India (SII) had said that they had received the first emergency use authorisation (EUA) for COVID-19 vaccine in Indonesia.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3mN8exe
via IFTTT